Clinical Trial Update: BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis [Phase 1]

View source ↗

Summary

Completed Phase 1 bioequivalence study of a calcipotriene hydrate and betamethasone dipropionate topical suspension for scalp psoriasis; sponsor Tolmar Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Drugs mentioned

• Taclonex (calcipotriene hydrate and betamethasone dipropionate) topical suspension (Calcipotriene hydrate and Betamethone dipropionate topical suspension)

Snippet

Sponsor: Tolmar Inc. | Conditions: Scalp Psoriasis | Phase 1 | Status: COMPLETED